Among the newer antipsychotic drugs for schizophrenia are a type called dopamine partial agonists. They get this name from the way they work in your brain. You might also hear them called dopamine ...

Is your medication doing more harm than good? Could it be a sign that you have tardive dyskinesia? Here's what you need to ...

Neuroleptic malignant syndrome is characterized by fever, muscular rigidity, and dysautonomia after exposure to dopamine-blocking agents, especially antipsychotic drugs. Clinical criteria for ...

Reviva was testing brilaroxazine, an antipsychotic and dopamine-serotonin system modulator, in the open-label extension portion of the ongoing RECOVER study. The study enrolled 435 patients who ...

Most prescription antipsychotic medications work by blocking the class of brain receptors that respond to a neurotransmitter called dopamine -- a cornerstone molecule of the brain's reward system ...

Haloperidol is an antipsychotic drug commonly used to treat ... The drug works by blocking dopamine D2 receptors, which are highly expressed in the striatum, a region of the brain that plays ...

The study, including experiments in mice, offers early evidence in support of co-administering antipsychotic medications that block dopamine (DA) D 2-like receptors in the brain alongside drugs ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach. By Ellen Barry and Christina Jewett The Food and Drug Administration on ...

has approved Cobenfy (Bristol Myers Squibb), a first-in-class antipsychotic approved for schizophrenia. The drug targets cholinergic receptors as opposed to dopamine receptors, which has been the ...

For the past 70 years, schizophrenia treatments all targeted the same chemical: dopamine. While that works for some, it causes brutal side effects for others. An antipsychotic drug approved last ...